WVE
Wave Life Sciences Ltd
4.40$
-2.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5,530.5% | -0.4% | +10.3% | +62.7% | -4.0% | -1.8% | -25.9% | -29.3% | +87.8% | +28.1% | +81.3% | |
| – | +10,753.0% | -5.8% | -1.0% | +34.4% | -8.3% | +24.0% | -29.3% | -39.4% | +138.9% | +36.1% | +91.9% | |
| – | +15,283.6% | -6.8% | -5.2% | +22.7% | -15.8% | +25.4% | -18.4% | -41.2% | +126.4% | +50.8% | +99.3% | |
| – | +15,283.6% | -6.8% | -5.2% | +22.7% | -15.8% | +25.4% | -18.4% | -41.2% | +126.4% | +50.8% | +99.3% | |
| – | -91.0% | – | – | +900.0% | +100.0% | +50.0% | -100.0% | – | – | -93.3% | -10.3% | |
| – | -100.0% | – | – | – | – | +8.4% | – | – | – | – | – | |
| – | +119.8% | +208.6% | +217.6% | +46.1% | +36.4% | -46.4% | -23.7% | -22.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,209.9% | +151.0% | +40.3% | +429.6% | -4.5% | -11.3% | -7.5% | +9.7% | +22.9% | -39.4% | -21.3% | |
| – | +332.9% | +218.4% | +61.4% | +562.8% | -9.1% | +2.4% | -47.0% | +11.4% | +160.7% | -40.5% | -14.3% | |
| – | -85.5% | +0.0% | +480.6% | +542.2% | +40.3% | +14.5% | +33.6% | +10.8% | +22.2% | +13.8% | +9.5% | |
| – | +2,148.8% | +75.8% | +53.7% | +72.3% | -30.7% | +52.0% | -47.2% | +132.3% | -24.1% | +26.7% | -3.5% | |
| – | +0.0% | -79.5% | -100.0% | – | – | – | – | – | – | – | – | |
| – | +7,472.3% | -12.1% | +3.7% | -47.5% | -2.4% | +26.6% | -64.2% | -238.8% | – | +428.7% | +151.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.0% | +5.8% | +16.3% | +9.3% | +16.9% | +15.8% | +32.1% | +52.2% | +34.5% | +30.3% | +22.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.